Mesenchymal Stem Cells: The Next Generation of Pain Treatments

7 September 2020
|In News
|By Regeneus Ltd.

Regeneus CEO Leo Lee is featured in the October 2020 edition of the European Pharmaceutical Review, writing on the field of regenerative medicine and its potential to dramatically transform the way that pain is treated.

Read Leo’s full article in the European Pharmaceutical Review October 2020 digital edition here.